908 Devices Inc (MASS)
5.47
-0.15
(-2.67%)
USD |
NASDAQ |
Apr 25, 10:45
908 Devices Enterprise Value: 39.27M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 39.27M |
April 23, 2024 | 37.30M |
April 22, 2024 | 38.28M |
April 19, 2024 | 37.96M |
April 18, 2024 | 38.61M |
April 17, 2024 | 38.28M |
April 16, 2024 | 44.87M |
April 15, 2024 | 44.87M |
April 12, 2024 | 54.08M |
April 11, 2024 | 65.93M |
April 10, 2024 | 62.64M |
April 09, 2024 | 84.03M |
April 08, 2024 | 71.19M |
April 05, 2024 | 65.60M |
April 04, 2024 | 68.23M |
April 03, 2024 | 71.85M |
April 02, 2024 | 71.85M |
April 01, 2024 | 81.40M |
March 28, 2024 | 102.79M |
March 27, 2024 | 83.04M |
March 26, 2024 | 71.52M |
March 25, 2024 | 69.88M |
March 22, 2024 | 74.81M |
March 21, 2024 | 80.74M |
March 20, 2024 | 82.71M |
Date | Value |
---|---|
March 19, 2024 | 78.43M |
March 18, 2024 | 74.49M |
March 15, 2024 | 75.47M |
March 14, 2024 | 74.81M |
March 13, 2024 | 86.33M |
March 12, 2024 | 85.35M |
March 11, 2024 | 73.50M |
March 08, 2024 | 80.08M |
March 07, 2024 | 82.71M |
March 06, 2024 | 89.62M |
March 05, 2024 | 83.37M |
March 04, 2024 | 89.43M |
March 01, 2024 | 93.33M |
February 29, 2024 | 93.33M |
February 28, 2024 | 97.56M |
February 27, 2024 | 98.86M |
February 26, 2024 | 81.95M |
February 23, 2024 | 82.93M |
February 22, 2024 | 85.53M |
February 21, 2024 | 80.65M |
February 20, 2024 | 85.85M |
February 16, 2024 | 89.43M |
February 15, 2024 | 105.36M |
February 14, 2024 | 95.28M |
February 13, 2024 | 86.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
12.54M
Minimum
Nov 09 2023
1.901B
Maximum
Feb 16 2021
447.07M
Average
281.70M
Median
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 984.38M |
Retractable Technologies Inc | -13.19M |
Xtant Medical Holdings Inc | 131.97M |
Asensus Surgical Inc | 45.03M |
Catheter Precision Inc | 0.9737M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.429M |
Revenue (Quarterly) | 14.35M |
Total Expenses (Quarterly) | 24.06M |
EPS Diluted (Quarterly) | -0.23 |
Gross Profit Margin (Quarterly) | 50.69% |
Profit Margin (Quarterly) | -51.77% |
Earnings Yield | -20.66% |
Normalized Earnings Yield | -20.66 |